Grace Therapeutics, Inc. (GRCE)

Operating Expenses

$25.69M

TTM · Period ending: · USD

GRCE logo

GRCE Operating Expenses

Latest reported$25.69M
GRCE Operating Expenses ($1.19M → $25.69M)
High-resolution chart · PNG

GRCE operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
11,077,000
23,752,730
17,440,292
70,541,289
19,478,039
26,101,116
48,831,870
42,532,137
15,251,546
7,952,135
7,033,068
11,503,138
9,894,062
7,128,261
6,556,008
3,217,706
1,538,732
1,191,528
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.